Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species - PubMed (original) (raw)

Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species

Jérôme Alexandre et al. Cancer Res. 2007.

Abstract

Generation of reactive oxygen species (ROS) has been observed in cancer cells treated with paclitaxel, but the underlying mechanisms and therapeutic implications remain unclear. In the present study, we showed that paclitaxel promoted ROS generation through enhancing the activity of NADPH oxidase (NOX) associated with plasma membranes. Treatment of breast cancer cells caused an increased translocation of Rac1, a positive regulatory protein of NOX, to the membrane fraction. The paclitaxel-induced ROS generation occurred rapidly within several hours of drug exposure, with O(2)(-) and H(2)O(2) accumulation mainly outside the cells while the intracellular ROS remained unchanged. Importantly, the increase in extracellular ROS caused lethal damage to the bystander cancer cells not exposed to paclitaxel, as shown by two different methods using coculture systems where the bystander cells were differentiated from the paclitaxel-treated cells by fluorescent or radioactive labeling. This cytotoxic bystander effect was also observed with other microtubule-targeted agents vincristine and taxotere but not with 5-fluorouracil or doxorubicin. This toxic bystander effect was enhanced by CuZnSOD that converts O(2)(-) to H(2)O(2) and was abolished by a catalase that eliminates H(2)O(2). Furthermore, paclitaxel was able to induce an almost complete inhibition of proliferation of the bystander cells in the coculture system. Our study revealed a novel mechanism by which paclitaxel induces toxic bystander effect through generation of extracellular H(2)O(2) from the membrane-associated NOX. This may contribute to the potent anticancer activity of paclitaxel and provide a novel basis to improve the clinical use of this important drug.

PubMed Disclaimer

Cited by

Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: hirsutanol A inhibits tumor growth through ROS production.
Yang F, Chen WD, Deng R, Zhang H, Tang J, Wu KW, Li DD, Feng GK, Lan WJ, Li HJ, Zhu XF. Yang F, et al. J Transl Med. 2013 Feb 8;11:32. doi: 10.1186/1479-5876-11-32. J Transl Med. 2013. PMID: 23394457 Free PMC article.
Involvement of AMP-activated protein kinase in mediating pyrrolo-1,5-benzoxazepine-induced apoptosis in neuroblastoma cells.
Lennon JC, Butini S, Campiani G, O'Meara A, Williams DC, Zisterer DM. Lennon JC, et al. Invest New Drugs. 2016 Oct;34(5):663-76. doi: 10.1007/s10637-016-0366-3. Epub 2016 Jun 22. Invest New Drugs. 2016. PMID: 27334143
Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in Ovarian Cancer SKOV3-TR Cells.
Lim YJ, Kim HS, Bae S, So KA, Kim TJ, Lee JH. Lim YJ, et al. Molecules. 2024 Jan 4;29(1):274. doi: 10.3390/molecules29010274. Molecules. 2024. PMID: 38202856 Free PMC article.
Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.
Miller MA, Weissleder R. Miller MA, et al. Adv Drug Deliv Rev. 2017 Apr;113:61-86. doi: 10.1016/j.addr.2016.05.023. Epub 2016 Jun 4. Adv Drug Deliv Rev. 2017. PMID: 27266447 Free PMC article. Review.
Optical Redox Imaging of Treatment Responses to Nampt Inhibition and Combination Therapy in Triple-Negative Breast Cancer Cells.
Podsednik A, Jiang J, Jacob A, Li LZ, Xu HN. Podsednik A, et al. Int J Mol Sci. 2021 May 25;22(11):5563. doi: 10.3390/ijms22115563. Int J Mol Sci. 2021. PMID: 34070254 Free PMC article.

Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species - PubMed (original) (raw)